The SLC22A2 gene gives kidney cells instructions for a transporter that moves certain medicines and natural waste chemicals from the blood into urine. This gene helps your body clear substances such as metformin and creatinine, a waste product measured on kidney blood tests. If the gene works less well, some drugs may stay in the body longer, and creatinine levels may look higher than expected even when kidney function is otherwise stable. Most variants in this gene do not cause symptoms on their own, but they can matter when medicines are prescribed.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or direct activities in the body. Some genes carry the information needed to produce proteins, the functional parts of cells. Other genes mainly regulate when certain processes occur, where they occur, and how strongly they are active. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can read more in the LearnHub.
Overview
SLC22A2Gene function
What if the gene works
The SLC22A2 gene helps kidney cells move certain medicines and natural charged substances from the blood toward urine. This supports the body’s normal clearing of waste and some drugs.
Risk
What if the gene does not work
Milder to more severe variants in the SLC22A2 gene can reduce or alter how kidney cells move creatinine and many medicines. This may lower transporter activity at the cell surface and reduce secretion into urine.
Treatment
What does that mean for your treatment
No SLC22A2-specific treatment or drug choice approach is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the SLC22A2 gene. The SLC22A2 gene is being studied as a biomarker for how some medicines, including cisplatin and metformin, are handled by the body and for the chance of kidney side effects.
Gene function
What if the gene works
Your kidneys clear many small substances from the blood every day. The SLC22A2 gene helps with this steady cleanup by making a transporter found mainly in kidney cells. That transporter moves selected positively charged substances from the blood into the cells, where they can be prepared for removal in urine.
The SLC22A2 gene makes a transporter that sits on the blood-facing side of kidney tubule cells. It brings selected positively charged substances into these cells.
It helps move normal body wastes such as creatinine, a substance released during normal muscle activity. This supports the kidneys as they prepare waste for removal in urine.
The same transporter also carries many medicines and other small charged compounds. This is part of how the SLC22A2 gene helps the kidneys clear medicines from the body.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to, or sometimes cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC22A2 gene can alter the OCT2 transporter’s shape, stability, or placement on the cell surface, which may reduce how well it moves certain small charged molecules into cells. This helps explain how SLC22A2 gene variants affect transporter function at a cellular level. Some variants have a mild effect and only partly lower activity, while more disruptive variants can greatly reduce transport or stop it altogether.
How variants are linked to conditions
Variants in the SLC22A2 gene do not yet have a broadly confirmed link to a specific health condition, although research on SLC22A2 gene variants and disease risk is still developing. If you have a reported change in the SLC22A2 gene, your doctor or genetic counselor can explain what it may mean in the context of your own health and family history.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific everyday factors that clearly increase or reduce health risk related to the SLC22A2 gene itself. SLC22A2 is most often discussed because changes in it can affect how some medicines move through the body, so personal concerns are best reviewed with a doctor or genetic counselor.
Inheritance of SLC22A2 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for a specific SLC22A2-related condition, so how SLC22A2 gene variants are inherited is usually discussed in the context of general gene inheritance rather than a single dominant or recessive syndrome. The SLC22A2 gene is located on chromosome 6, which is an autosome. That means you inherit one copy of the SLC22A2 gene from each parent. In families, a variant in this gene can be passed from either mother or father to children of any sex.
What does my SLC22A2 result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific health condition for SLC22A2. If you have a SLC22A2 result and want to understand what it could mean for close relatives, the meaning depends on the exact change found and why the test was done.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SLC22A2 gene, doctors use genetic testing for SLC22A2 variants. This usually checks DNA from a blood or saliva sample with sequencing, a method that reads the gene's code and looks for known or rare variants.
When should I consider getting a genetic test?
There isn't yet a broadly established SLC22A2-specific clinical reason for testing. Decisions about testing are usually based on your overall health, the medicines you take, and your personal or family history, ideally with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic findings can be informative, although what they reveal depends on the condition and the type of variant found. Factors such as lifestyle, environment, age, and medical history also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, moves, breaks down, or clears a drug. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medications. It focuses on the relationship between genes and drugs to help explain why the same treatment may work differently in different people. With many medicines, genes can influence either how powerfully a drug works or how the body handles it. This information can support treatment decisions that are more informed and tailored to the individual. More on this topic is available in the LearnHub.
Drugs influenced by the SLC22A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication decisions, so general questions about side effects, kidney-related drug safety, or how well a treatment is working are best discussed with your doctor. Research on the SLC22A2 gene has looked at whether it may affect how some people handle medicines such as metformin or cisplatin, but this is not used routinely to guide care.
History
The SLC22A2 gene entered medical research in the 1990s, when scientists were mapping a growing family of transport genes involved in moving small charged substances through cells. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect older kidney transport studies with modern human genetics. From these first observations, research expanded steadily. As more laboratories studied the SLC22A2 gene, it became part of a broader shift toward understanding why people can process some medicines differently. Its history is mainly scientific rather than public facing, but it has become well known in pharmacogenetics, the field that looks at how genes can influence drug response.